These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16257492)

  • 1. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
    Rebec GV; Conroy SK; Barton SJ
    Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
    Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
    Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.
    Traficante A; Riozzi B; Cannella M; Rampello L; Squitieri F; Battaglia G
    Neuroreport; 2007 Dec; 18(18):1997-2000. PubMed ID: 18007201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice.
    Bolivar VJ; Manley K; Messer A
    Brain Res; 2004 Apr; 1005(1-2):29-35. PubMed ID: 15044061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
    Domenici MR; Scattoni ML; Martire A; Lastoria G; Potenza RL; Borioni A; Venerosi A; Calamandrei G; Popoli P
    Neurobiol Dis; 2007 Nov; 28(2):197-205. PubMed ID: 17720507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
    Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
    J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbate modulation of sensorimotor processing in striatum of freely moving rats.
    Cortright JJ; Rebec GV
    Brain Res; 2006 May; 1092(1):108-16. PubMed ID: 16753136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice.
    Klapstein GJ; Levine MS
    J Neurophysiol; 2005 Feb; 93(2):758-65. PubMed ID: 15371492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.
    Estrada-Sánchez AM; Montiel T; Segovia J; Massieu L
    Neurobiol Dis; 2009 Apr; 34(1):78-86. PubMed ID: 19168136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
    Crocker SF; Costain WJ; Robertson HA
    Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
    Cepeda C; Starling AJ; Wu N; Nguyen OK; Uzgil B; Soda T; André VM; Ariano MA; Levine MS
    J Neurosci Res; 2004 Dec; 78(6):855-67. PubMed ID: 15505789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice.
    Cipriani S; Bizzoco E; Gianfriddo M; Melani A; Vannucchi MG; Pedata F
    Exp Neurol; 2008 Sep; 213(1):163-70. PubMed ID: 18586241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
    Martire A; Calamandrei G; Felici F; Scattoni ML; Lastoria G; Domenici MR; Tebano MT; Popoli P
    Neurosci Lett; 2007 Apr; 417(1):78-83. PubMed ID: 17331645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
    Popovic N; Maingay M; Kirik D; Brundin P
    Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
    Petersén A; Chase K; Puschban Z; DiFiglia M; Brundin P; Aronin N
    Exp Neurol; 2002 May; 175(1):297-300. PubMed ID: 12009780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
    Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice.
    Ferrante A; Martire A; Armida M; Chiodi V; Pézzola A; Potenza RL; Domenici MR; Popoli P
    Brain Res; 2010 Apr; 1323():184-91. PubMed ID: 20138162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal transplantation in a transgenic mouse model of Huntington's disease.
    Dunnett SB; Carter RJ; Watts C; Torres EM; Mahal A; Mangiarini L; Bates G; Morton AJ
    Exp Neurol; 1998 Nov; 154(1):31-40. PubMed ID: 9875265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
    André VM; Cepeda C; Venegas A; Gomez Y; Levine MS
    J Neurophysiol; 2006 Apr; 95(4):2108-19. PubMed ID: 16381805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene.
    Rebec GV; Barton SJ; Ennis MD
    J Neurosci; 2002 Jan; 22(2):RC202. PubMed ID: 11784814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.